Novo Nordisk surpasses LVMH and becomes Europe's most valuable

Novo Nordisk (NOVOB) Briefly Overtakes LVMH (MC) as Biggest European Company - Bloomberg

Novo Nordisk acquires Canadian biotech company for up to USD 1.1bn — MedWatch

Libertex Limassol

Who Is Lars Fruergaard Jorgensen, the CEO Behind Ozempic and Wegovy?

12 European Giants Visualized

Wegovy: Biggest pharma blockbuster? All about Wegovy, Novo Nordisk's obesity drug, that cuts risk of heart attacks and strokes by 20% - The Economic Times

Bernard Arnault's LVMH sees slow quarterly sales growth

LVMH becomes first European company to reach €400 billion market cap

Danish Novo Nordisk surpasses LVMH as Europe's most valuable company - Scandasia

Novo Nordisk Becomes Europe's Most Valuable Company, Surpassing LVMH

Novo Nordisk stock pops on Wegovy-fueled sales

Flagship drug makes Novo Nordisk Europe's most valuable company, dethroning LVMH

Ozempic-maker Novo Nordisk briefly becomes Europe's most valuable firm

Largest Non-US Companies (2023)

Weight-loss drug frenzy lifts Novo Nordisk as Europe's most valuable company